Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XPO1 | O14980 | 1/20 | 0.33 |
| ▸ | PDCD4 | Q53EL6 | 2/20 | 0.32 |
| ▸ | TUBAL3 | A6NHL2 | 1/20 | 0.30 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.30 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.30 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.30 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.30 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.30 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.30 |
| ▸ | TUBA8 | Q9NY65 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17866952 | 0.94 | PDCD4 (0.33) | XPO1PDCD4 | |
| SCHEMBL9992232 | 0.83 | ELANE (0.32) | — | |
| SCHEMBL9995108 | 0.79 | PDCD4 (0.30) | PDCD4 | |
| SCHEMBL9993662 | 0.78 | PDCD4 (0.31) | PDCD4 | |
| SCHEMBL9992410 | 0.74 | CES2 (0.32) | PDCD4 | |
| SCHEMBL3505080 | 0.70 | PDCD4 (0.40) | PDCD4 | |
| SCHEMBL9991197 | 0.69 | PDCD4 (0.36) | XPO1PDCD4TUBAL3TUBA3CTUBA1B | |
| SCHEMBL31264317 | 0.68 | NLRP3 (0.34) | PDCD4 | |
| SCHEMBL1895638 | 0.68 | PDCD4 (0.43) | PDCD4 | |
| SCHEMBL31264316 | 0.68 | NLRP3 (0.34) | PDCD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8177896-B2 | Antifouling furan-2-one derivatives | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2012-05-15 | — | — | US | disclosed |
| US-20110185944-A1 | ANTIFOULING FURAN-2-ONE DERIVATIVES | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2011-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110185944-A1 | ANTIFOULING FURAN-2-ONE DERIVATIVES | FSCN1, PFAS, PFN1 | XPO1 1361/4885PDCD4 3370/4885TUBAL3 3368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.